{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T02:02:40Z","timestamp":1762480960185,"version":"build-2065373602"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T00:00:00Z","timestamp":1664928000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology Reports"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.gore.2022.101076","type":"journal-article","created":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T14:45:20Z","timestamp":1665758720000},"page":"101076","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Multisite gynecologic endometrioid adenocarcinomas: Can mutation profiling be used to distinguish synchronous primary cancers from metastases?"],"prefix":"10.1016","volume":"44","author":[{"given":"Dominique","family":"Barnes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nissreen","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lien","family":"Hoang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Anglesio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert L.","family":"Hollis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlie","family":"Gourley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather C.","family":"Stuart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark S.","family":"Carey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gavin C.E.","family":"Stuart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gore.2022.101076_b0005","doi-asserted-by":"crossref","unstructured":"Anglesio, M.S., Wang, Y.K., Maassen, M., Horlings, H.M., Bashashati, A., Senz, J., et al., 2016. Synchronous Endometrial and Ovarian Carcinomas: Evidence of Clonality. Available from: https:\/\/academic.oup.com\/jnci\/article\/108\/6\/djv428\/2412607.","DOI":"10.1093\/jnci\/djv428"},{"key":"10.1016\/j.gore.2022.101076_b0015","doi-asserted-by":"crossref","unstructured":"Castro, Iris M., M.D.; Connell, Philip P., M.D.; Waggoner, Steven, M.D.; Rotmensch, Jacob, M.D.; Mundt, Arno J. MD. Synchronous Ovarian and Endometrial Malignancies\u00a0: American Journal of Clinical Oncology [Internet]. American Journal of Clinical Oncology. 2000 [cited 2020 Nov 1]. p. 521\u20135. Available from: https:\/\/journals.lww.com\/amjclinicaloncology\/fulltext\/2000\/10000\/synchronous_ovarian_and_endometrial_malignancies.18.aspx?casa_token=5HN_unoYOQYAAAAA:fe6qie75A_vk_Cqw1An23YjigFhfj6JGSWsufbSatg4QEd3F9qeNJFB_Q-IxPxbNpYUreRUNjQw7j1WnMYefEAkk.","DOI":"10.1097\/00000421-200010000-00018"},{"issue":"6","key":"10.1016\/j.gore.2022.101076_b0025","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/jnci\/djv442","article-title":"Making a Difference: Distinguishing Two Primaries From Metastasis in Synchronous Tumors of the Ovary and Uterus","volume":"108","author":"Dizon","year":"2016","journal-title":"JNCI J. Natl. Cancer Inst. [Internet]."},{"key":"10.1016\/j.gore.2022.101076_b0030","doi-asserted-by":"crossref","unstructured":"Fujita M, Wada H, Inoue M, Okudaira Y, Shroyer KR. A N A T O M I C P A T H O L O G Y [Internet]. [cited 2020 Nov 10]. Available from: https:\/\/academic.oup.com\/ajcp\/article\/105\/3\/350\/1756533.","DOI":"10.1093\/ajcp\/105.3.350"},{"issue":"7447","key":"10.1016\/j.gore.2022.101076_b0035","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Getz","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.gore.2022.101076_b0040","doi-asserted-by":"crossref","unstructured":"Hollis, R.L., Thomson, J.P., Stanley, B., Churchman, M., Meynert, A.M., Rye, T., et al. Molecular stratification of endometrioid ovarian carcinoma predicts clinical outcome. Available from https:\/\/doi.org\/10.1038\/s41467-020-18819-5.","DOI":"10.1038\/s41467-020-18819-5"},{"key":"10.1016\/j.gore.2022.101076_b0045","doi-asserted-by":"crossref","unstructured":"Hollis, R.L., Stanley, B., Thomson, J.P., Churchman, M., Croy, I., Rye, T., et al., 2021. Integrated molecular characterisation of endometrioid ovarian carcinoma identifies opportunities for stratification. NPJ Precis. Oncol. [Internet]. 2021 Jun 2 [cited 2021 Nov 14];5(1), 47\u201347. Available from: https:\/\/europepmc.org\/articles\/PMC8172925.","DOI":"10.1038\/s41698-021-00187-y"},{"key":"10.1016\/j.gore.2022.101076_b0050","unstructured":"Ovary Source: Globocan 2018 [Internet]. 2018 [cited 2020 Sep 27]. Available from: http:\/\/gco.iarc.fr\/today."},{"key":"10.1016\/j.gore.2022.101076_b0055","doi-asserted-by":"crossref","unstructured":"Reijnen C, K\u00fcsters-Vandevelde HVN, Ligtenberg MJL, Bulten J, Oosterwegel M, Snijders MPLM, et al. Molecular profiling identifies synchronous endometrial and ovarian cancers as metastatic endometrial cancer with favorable clinical outcome. 2020; Available from: http:\/\/www.federa.org.","DOI":"10.1002\/ijc.32907"},{"key":"10.1016\/j.gore.2022.101076_b0060","unstructured":"Sato, N., Tsunoda, H., Nishida, M., Morishita, Y., Takimoto, Y., Kubo, T., et al., 2000. Loss of Heterozygosity on 10q23.3 and Mutation of the Tumor Suppressor Gene PTEN in Benign Endometrial Cyst of the Ovary: Possible Sequence Progression from Benign Endometrial Cyst to Endometrioid Carcinoma and Clear Cell Carcinoma of the Ovary 1. Vol. 60, CANCER RESEARCH."},{"key":"10.1016\/j.gore.2022.101076_b0065","doi-asserted-by":"crossref","unstructured":"Schultheis AM, Ng CKY, De Filippo MR, Piscuoglio S, Macedo GS, Gatius S, et al. Massively Parallel Sequencing-Based Clonality Analysis of Synchronous Endometrioid Endometrial and Ovarian Carcinomas. 2016 [cited 2020 Nov 28]; Available from: https:\/\/academic.oup.com\/jnci\/article\/108\/6\/djv427\/2412576.","DOI":"10.1093\/jnci\/djv427"},{"key":"10.1016\/j.gore.2022.101076_b0070","unstructured":"Synchronous Ovarian and Endometrial Malignancies\u00a0: American Journal of Clinical Oncology [Internet]. [cited 2020 Nov 8]. Available from: https:\/\/journals.lww.com\/amjclinicaloncology\/fulltext\/2000\/10000\/synchronous_ovarian_and_endometrial_malignancies.18.aspx?casa_token=o-H0mF8aEScAAAAA:mbdNu9yxjpdwuXi_JChQDyxdvorHWlZQxiVhfDFPoiWG2o2Df-xUnZSxfIl60k67xCSbWe6tEZ8wfSKVEfHxU_Eg."},{"issue":"1","key":"10.1016\/j.gore.2022.101076_b0075","first-page":"1","article-title":"Comparison and analysis of the clinicopathological features of SCEO and ECOM","volume":"12","author":"Wang","year":"2019","journal-title":"J. Ovarian Res. [Internet]."}],"container-title":["Gynecologic Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578922001564?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578922001564?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T01:58:12Z","timestamp":1762480692000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352578922001564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":13,"alternative-id":["S2352578922001564"],"URL":"https:\/\/doi.org\/10.1016\/j.gore.2022.101076","relation":{},"ISSN":["2352-5789"],"issn-type":[{"type":"print","value":"2352-5789"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multisite gynecologic endometrioid adenocarcinomas: Can mutation profiling be used to distinguish synchronous primary cancers from metastases?","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gore.2022.101076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101076"}}